CD8A and neoplasm: Hofmann et al. [63] achieved tumor regression in half of the treated subjects using this strategy, whereas Molenkamp et al. [64] and Brody et al. [65] showed that CpG-ODN administration, either alone or combined with radiotherapy induced tumor regression, accompanied by the generation of tumor-specific CD8+ T cells.